Oncologische huid- en nagelafwijkingen aan de voeten: tijd voor interdisciplinaire samenwerking

Kwakman JJM, Elshot YS, Punt CJA, et al. Management of cytotoxic chemotherapy-induced hand-foot syndrome. Oncol Rev. 2020;14(1):442. https://doi.org/10.4081/oncol.2020.442.

McLellan B, Ciardiello F, Lacouture ME, et al. Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management. Ann Oncol. 2015;26:2017.

Alessandrini A, Starace M, Cerè G, et al. Management and outcome of Taxane-induced nail side effects: experience of 79 patients from a single centre. Skin Appendage Disord. 2019;5(5):276–82.

Robert C, Sibaud V, Mateus C, et al. Nail toxicities induced by systemic anticancer treatments. Lancet Oncol. 2015;16(4):181–9.

Capriotti K, Anadkat M, Choi J, et al. A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for cancer therapy-associated Paronychia. Invest New Drugs. 2019;37:1247–56.